Shopping Cart
- Remove All
Your shopping cart is currently empty
AS2717638 is an orally active and selective lysophosphatidic acid receptor 5 (LPA5) antagonist (IC50: 38 nM for hLPA5). It also significantly improves PGF2α-, PGE2-, and AMPA-induced allodynia.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $54 | In Stock | |
| 5 mg | $127 | In Stock | |
| 10 mg | $210 | In Stock | |
| 25 mg | $421 | In Stock | |
| 50 mg | $679 | In Stock | |
| 100 mg | $1,070 | In Stock | |
| 200 mg | $1,450 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $140 | In Stock |
| Description | AS2717638 is an orally active and selective lysophosphatidic acid receptor 5 (LPA5) antagonist (IC50: 38 nM for hLPA5). It also significantly improves PGF2α-, PGE2-, and AMPA-induced allodynia. |
| Targets&IC50 | LPA5 (human):38 nM |
| Molecular Weight | 447.48 |
| Formula | C25H25N3O5 |
| Cas No. | 2148339-28-8 |
| Smiles | COc1cc2c(cn(-c3noc4ccc(C)cc34)c(=O)c2cc1OC)C(=O)N1CCCCC1 |
| Relative Density. | 1.321 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 54 mg/mL (120.7 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.